Trial
NCT01898377
Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Chronic Graft-versus-host Disease
Intervention
Imatinib mesylate, Mycophenolate mofetil
Why stopped
New treatment option introduced for patients with the study indication
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-23